Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars
RecruitingHealthy volunteers welcome
A Prospective, Multi-center, Pilot Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Scars
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * 18 years of age or older * Fitzpatrick scale I-VI. * Any type of scar except for keloid scars * Able to provide written informed consent, understand and willing to comply with study related procedures and follow-ups. Exclusion Criteria: * Previous treatment of the scar tissue within last 6 months. * Silicone, fat, collagen or synthetic material in the treatment area. * History of keloid formation. * Active smokers (smoking more than ½ pack per day) or having quit smoking (½ pack per day) for less than 3 months. * Active, chronic, or recurrent infection. * Compromised immune system (e.g. diabetes). * Hypersensitivity to analgesic agents. * Co-morbid condition that could limit ability to participate in the study or to comply with follow-up requirements. * Pregnant or breastfeeding. * Any issue that, at the discretion of the investigator, would contra-indicate the subject's participation. * Any medication that may cause bleeding such as anticoagulants. * Allergy to lidocaine and/or epinephrine
About the study
A study to evaluate the safety and effectiveness of a micro coring device for the treatment of scars.
What is being tested
- MCD (device)
Sponsor: Cytrellis Biosystems, Inc. · Participants: 30 · Started: Sep 13, 2018
Contact the study team
Official record on ClinicalTrials.gov — NCT03782038
Locations in the U.S.
| Florida | Miami Dermatology & Laser Institute, Miami |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.